Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Change in Acquisitions & Divestments (2019 - 2025)

aTYR PHARMA's Change in Acquisitions & Divestments history spans 7 years, with the latest figure at $29.3 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 46.54% year-over-year to $29.3 million; the TTM value through Dec 2025 reached $88.5 million, up 2.39%, while the annual FY2025 figure was $88.5 million, 2.39% up from the prior year.
  • Change in Acquisitions & Divestments reached $29.3 million in Q4 2025 per ATYR's latest filing, up from $19.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $33.6 million in Q3 2023 to a low of $2.3 million in Q1 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $19.6 million, with a median of $20.3 million recorded in 2023.
  • Peak YoY movement for Change in Acquisitions & Divestments: tumbled 84.3% in 2021, then skyrocketed 530.43% in 2022.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $8.3 million in 2021, then surged by 238.09% to $28.1 million in 2022, then fell by 2.18% to $27.5 million in 2023, then dropped by 27.27% to $20.0 million in 2024, then surged by 46.54% to $29.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Change in Acquisitions & Divestments are $29.3 million (Q4 2025), $19.0 million (Q3 2025), and $21.5 million (Q2 2025).